The U.S. patent office will review patents on Alexion Pharmaceuticals Inc’s blood disorder treatment Soliris, after Amgen Inc challenged them, court filings showed on Friday.
An unnamed hospital in Oklahoma used contaminated gastroscopes in procedures performed on nearly a thousand patients in recent months, device maker Pentax Medical told U.S. regulators last month, putting the patients at risk of exposure to bacteria that can cause infections.
Women account for only a little over one third of appointments at a major hospital in India’s capital, New Delhi, highlighting extensive gender discrimination in access to healthcare services, researchers say.
The Federal Trade Commission is investigating the marketing practices of e-cigarette maker Juul Labs Inc, the Wall Street Journal reported on Thursday, citing people familiar with the matter.
The U.S. Food and Drugs Administration said on Wednesday it was expanding its investigation into impurities in U.S. generic drugs beyond a class of medicines for high blood pressure known as angiotensin II receptor blockers (ARBs).
An Oklahoma judge on Monday ordered Johnson & Johnson to pay $572.1 million to the state for its part in fueling an opioid epidemic by deceptively marketing addictive painkillers, a sum that was substantially less than investors had expected, driving up J&J’s shares.
An Oklahoma judge on Monday will decide whether Johnson & Johnson should be held liable in a $17 billion lawsuit alleging the drugmaker’s marketing practices fueled the opioid epidemic by flooding the market with painkillers.
Congolese authorities and health workers vaccinated more than 200,000 people against Ebola in August, the government said on Sunday, using a Merck vaccine they hope will help rein in the world’s second worst epidemic.
(Reuters Health) – Family caregivers for dementia patients don’t sleep as long or as well as other adults of the same age, a new study suggests.
A proposed switch to universal health coverage in South Africa will be managed in a fiscally responsible way, a senior presidential aide told Reuters, forecasting the landmark reform would cost the state $2.2 billion per year by 2025/26.
Recent Comments